14 completed, 4 recruiting, 4 unknown, 2 not yet recruiting. 9 Not applicable, 4 Phase 3, 2 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 9 | Completed 5, Unknown 2, Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 4 | Completed 2, Recruiting 2 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow Oncologic Disorders: new trials by email Literature Review of Oncologic Disorders trials Research Report on Oncologic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immersive Virtual Reality Applied to Therapeutic Physical Exercise in Cellular Therapy Intervention with IVR, Control - Hematologic Diseases, Hematopoietic Stem Cell Transplantation | Not applicable | Not yet recruiting | Fundacin Biomedica Galicia Sur | 144 | 2026-09-15 | 2026-09-02 |
| Physical Exercise During the Cancer Care Pathway Cancer, Treatment-Related, Cancer | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 370 | 2026-06-15 | 2026-06-26 | |
| LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL) LLM-Generated Plain-Language Patient Synopsis - Hematologic Neoplasms, Oncologic Disorders | Not applicable | Recruiting | Technical University of Munich | 150 | 2026-04-01 | 2026-04-16 |
| Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types [18F]AlF-FAPI-74 PET/CT - Oesophageal Cancer, Gastric Cancer | Phase 2 / Phase 3 | Recruiting | KU Leuven | 109 | 2025-02-06 | 2026-11-06 |
| Advanced Imaging Holistic Omics Biobank Computed Tomography (CT) using Photon Counting CT scanner (Neaotom Alpha, Siemens) and Magnetic Resonance (MRI) - Oncologic Disorders, Neurologic Disorder | Recruiting | IRCCS San Raffaele | 50000 | 2024-09-15 | 2026-01-15 | |
| The Right to be Forgotten in the AYA Population: Patients' Experience and Perspectives (Diritto All'Oblio) Oncologic Disorders | Unknown | Centro di Riferimento Oncologico - Aviano | 60 | 2023-11-16 | 2024-01-29 | |
| Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments Esmolol Injection [Brevibloc] - Cirrhosis, Diabetes Mellitus | Phase 3 | Recruiting | Consorcio Centro de Investigación Biomédica en Red (CIBER) | 1000 | 2023-04-18 | 2024-10-01 |
| Study of Factors Associated With Significant MYoCArdian Uptake on 68Ga-DOTATOC PET Scans for Oncology Oncologic Disorders | Completed | Central Hospital, Nancy, France | 210 | 2022-09-01 | 2024-06-21 | |
| Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors Cardiac Rehabilitation Program, Community exercise intervention - Oncologic Disorders, Cardiovascular Diseases | Not applicable | Completed | Associacao de Investigacao de Cuidados de Suporte em Oncologia | 80 | 2021-09-30 | 2022-10-04 |
| Horse-assisted Interventions in an Oncological Centre Horse-Assisted Intervention (HAI) - Breast Cancer, Oncologic Disorders | Not applicable | Completed | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 28 | 2021-06-14 | 2026-10-01 |
| COVID-19 Vaccination in Oncologic Patients Covid19, Oncologic Disorders | Completed | Krankenhaus Barmherzige Schwestern Linz | 1150 | 2021-04-19 | 2021-11-23 | |
| Hepatitis E Virus Infection in Oncological Patients ELISA testing - Hepatitis E Infection, Hepatitis; Epidemic | Not applicable | Completed | Medizinische Hochschule Brandenburg Theodor Fontane | 197 | 2020-09-01 | 2024-10-08 |
| Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2 Care pathway - Oncologic Disorders | Not applicable | Unknown | Ilyse Kenis | 500 | 2019-10-01 | 2019-10-29 |
| Nutrition Health Literacy of Cancer Patients and Their Support Networks. Nominal consensus group, Observational cohort (validity and reliability testing) - Cancer, Oncologic Disorders | Terminated | Nottingham University Hospitals NHS Trust | 58 | 2019-09-01 | 2023-08-21 | |
| Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up Oncological Rehabilitation - Oncologic Disorders | Unknown | Klinik Valens | 250 | 2019-01-01 | 2022-09-21 | |
| Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients Vancomycin Oral Capsule, Placebo Oral Capsule - Clostridium Difficile Infection, Hematologic Diseases | Phase 2 | Completed | Medical College of Wisconsin | 9 | 2018-06-01 | 2026-04-15 |
| Place of General Medical During Oncology Care Management medical questionnaire - Oncologic Disorders | Completed | Institut de Cancérologie de Lorraine | 197 | 2018-05-16 | 2020-08-12 | |
| Clinical Use of Pathogen Reduced Red Blood Cell Suspension Riboflavin+UV RBC, irradiated RBC - Oncologic Disorders, Hematologic Diseases | Phase 3 | Completed | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 50 | 2018-01-15 | 2018-12-24 |
| Oncologic Therapy Support Via Means of a Dedicated Mobile App mobile application - Thoracic Neoplasm, Pelvic Neoplasm | Not applicable | Unknown | Heidelberg University | 50 | 2017-07-01 | 2017-05-30 |
| Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students Patient Provider Orientation Scale, Interview performed by MHP student - Narrative Medicine, Chronic Disease | Withdrawn | University of Florida | 2017-03-01 | 2020-01-06 |
Showing 20 of 26. Sign in to see all of them.
Hematologic Diseases (7) · Neoplasms (6) · Breast Neoplasms (2) · Cardiovascular Diseases (2) · Diabetes Mellitus (2) · Hematologic Neoplasms (2) · Neoplasms, Second Primary (2) · Nervous System Diseases (2) · Stomach Neoplasms (2) · Autoimmune Diseases (1) · COVID-19 (1) · Chronic Disease (1) · Clostridium Infections (1) · Collagen Diseases (1) · Cystic Fibrosis (1)
Hemic and Lymphatic Diseases (9) · Neoplasms by Site (7) · Neoplasms (6) · Digestive System Diseases (5) · Behavior (3) · Digestive System Neoplasms (3) · Endocrine System Diseases (3) · Respiratory Tract Diseases (3) · Skin and Connective Tissue Diseases (3) · Breast Diseases (2) · Communication (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Glucose Metabolism Disorders (2) · Hematologic Diseases (2)
Choledochostomy (1) · Critical Pathways (1) · Magnetic Resonance Spectroscopy (1) · Methods (1) · Plasma Exchange (1) · Rituximab (1) · Surgical Procedures, Operative (1) · Vancomycin (1) · esmolol (1)
ARCIM Institute Academic Research in Complementary and Integrative Medicine (1) · Associacao de Investigacao de Cuidados de Suporte em Oncologia (1) · Baylor College of Medicine (1) · Central Hospital, Nancy, France (1) · Centro di Riferimento Oncologico - Aviano (1) · Consorcio Centro de Investigación Biomédica en Red (CIBER) (1) · Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1) · Fenwal, Inc. (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Fundacin Biomedica Galicia Sur (1) · Heidelberg University (1) · Hospital Universitari de Bellvitge (1) · IRCCS San Raffaele (1) · Ilyse Kenis (1) · Institut de Cancérologie de Lorraine (1)
France (4) · Germany (4) · United States (4) · Italy (3) · Spain (3) · Belgium (2) · Austria (1) · Portugal (1) · Romania (1) · Russia (1) · Switzerland (1) · United Kingdom (1)
Francesca Bomben, Dr (1) · Gennaro Galizia, MD (1) · Hans Geinitz, Univ.-Prof. (1) · Isabel-Elena Haller (1) · Jan Vagedes, MD (1) · Javier Bermejo Thomas, MD, PhD (1) · Jenny Despotovic, MD (1) · Laura J Miller, MBiol, PgDip (1) · Maurizio Mascarin, MD (1) · Nils Nicolay, PD Dr. Dr. (1) · Pavel Trakhtman, PhD (1)
PMID 11013547, PMID 11742607, PMID 19704190, PMID 26348734, PMID 26452199, PMID 27707993, PMID 27943501, PMID 29510971, PMID 37819656, PMID 38246842, PMID 38788778, PMID 41808418